Use of Group O RhD-Negative Red Cells in Patients with Critical Bleeding: Data from the Australian and New Zealand Massive Transfusion Registry

Sparrow Rosemary; Haysom Helen; Tacey Mark; McQuillen Zoe K.; Wood Erica M.

首页> 外文期刊>Transfusion: The Journal of the American Association of Blood Banks >Use of Group O RhD-Negative Red Cells in Patients with Critical Bleeding: Data from the Australian and New Zealand Massive Transfusion Registry

【24h】

Use of Group O RhD-Negative Red Cells in Patients with Critical Bleeding: Data from the Australian and New Zealand Massive Transfusion Registry

机译：在临界出血患者中使用组O RHD阴性红细胞：来自澳大利亚和新西兰的数据巨大输液登记

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Transfusion: The Journal of the American Association of Blood Banks》 |2018年第s1期|共1页
作者
Sparrow Rosemary; Haysom Helen; Tacey Mark; McQuillen Zoe K.; Wood Erica M.;
展开▼
作者单位

Monash Univ Dept Epidemiol &

Prevent Med Clayton Vic Australia;

Monash Univ Dept Epidemiol &

Prevent Med Clayton Vic Australia;

Monash Univ Dept Epidemiol &

Prevent Med Clayton Vic Australia;

Monash Univ Dept Epidemiol &

Prevent Med Clayton Vic Australia;

Monash Univ Dept Epidemiol &

Prevent Med Clayton Vic Australia;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Use of Group O RhD-Negative Red Cells in Patients with Critical Bleeding: Data from the Australian and New Zealand Massive Transfusion Registry [J] . Sparrow Rosemary, Haysom Helen, Tacey Mark, Transfusion: The Journal of the American Association of Blood Banks . 2018,第S1期

机译：在临界出血患者中使用组O RHD阴性红细胞：来自澳大利亚和新西兰的数据巨大输液登记
2. Clinical coding data algorithm to categorize type of gastrointestinal bleeding as a primary reason for massive transfusion: results from the Australian and New Zealand Massive Transfusion Registry [J] . Ket Shara N., Sparrow Rosemary L., McQuilten Zoe K., Vox Sanguinis: International Journal of Blood Transfusion and Immunohaematology . 2019,第8期

机译：临床编码数据算法将胃肠道出血的类型分类为大规模输血的主要原因：澳大利亚和新西兰大规模输血登记处的结果
3. Whole Blood Use and Patient Outcomes in Major Hemorrhage: Results From the Australian and New Zealand Massive Transfusion Registry (ANZ-MTR) [J] . Waters Neil, Sparrow Rosemary, Haysom Helen, Transfusion: The Journal of the American Association of Blood Banks . 2019,第S3期

机译：主要出血的全血和患者结果：澳大利亚和新西兰大规模输液登记处的结果（ANZ-MTR）
4. The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer [C] . Liuning Li, Jiaying Liu, Xiaoshu Chai, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
5. Trends and Significant Predictors of Post-operative Bleeding Requiring Blood Transfusion among Renal Cancer Patients Undergoing Nephrectomy [D] . Wen, Huei Hsun. 2019

机译：术后出血的趋势和重要预测因子，需要肾癌患者输血的肾病患者
6. Improving outcomes for hospital patients with critical bleeding requiring massive transfusion: the Australian and New Zealand Massive Transfusion Registry study methodology [O] . J. C. Oldroyd, K. M. Venardos, N. J. Aoki, 2016

机译：为需要大量输血的严重出血住院患者改善结果：澳大利亚和新西兰大规模输血注册研究方法
7. Improving outcomes for hospital patients with critical bleeding requiring massive transfusion: the Australian and New Zealand Massive Transfusion Registry study methodology [O] . J. C. Oldroyd, K. M. Venardos, N. J. Aoki, 2016

机译：为需要大量输血的严重出血住院患者改善结果：澳大利亚和新西兰大规模输血注册研究方法
8. Increased Plasma and Platelet to Red Blood Cell Ratios Improves Outcome in 466 Massively Transfused Civilian Trauma Patients. [R] . Holcomb, J. B., Wade, C. E., Michalek, J. E., 2008

机译：血浆和血小板增加至红细胞比率可改善466名大规模输血的平民创伤患者的预后。

Use of Group O RhD-Negative Red Cells in Patients with Critical Bleeding: Data from the Australian and New Zealand Massive Transfusion Registry

著录项

相似文献

相关主题

期刊订阅